STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

FENNEC PHARMACEUTICALS INC.

Filed

December 29, 2025

Period of Report

December 24, 2025

Accession Number

0001012975-25-000985